Hui Xie
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Extracellular vesicles in disease
- Epigenetics and DNA Methylation
Papers in
-
- Cancer-related molecular mechanisms research 7
- Breast Cancer Treatment Studies 5
-
- RNA modifications and cancer 7
- Histone Deacetylase Inhibitors Research 5
- Circular RNAs in diseases 5
- Epigenetics and DNA Methylation 5
- Wnt/β-catenin signaling in development and cancer 3
- Extracellular vesicles in disease 3
- Co-authors
- Ziyi Fu (9 shared papers)Shui Wang (6 shared papers)Ruilan Wang (7 shared papers)Xiaowei Wu (7 shared papers)Xiaoxiao Meng (7 shared papers)Wenbin Zhou (7 shared papers)Yong Zhu (5 shared papers)Yangyang Cui (7 shared papers)
- Journals
- Frontiers in Pharmacology (3 papers)Frontiers in Oncology (3 papers)Journal of Cellular Physiology (2 papers)Journal of Cellular and Molecular Medicine (2 papers)Journal of Biomedical Nanotechnology (2 papers)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Hui Xie
60 papers receiving 2.0k citations
Hui Xie's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 727
- Molecular Biology 1.2k
- Parasitology 78
- Oncology 283
- Pulmonary and Respiratory Medicine 286
Countries citing papers authored by Hui Xie
This map shows the geographic impact of Hui Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Xie more than expected).
Fields of papers citing papers by Hui Xie
This network shows the impact of papers produced by Hui Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Xie. The network helps show where Hui Xie may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Integrative Proteomic Characterization of Human Lung Adenocarcinoma Hit paper breakdown → | 2020 | 427 |
| 2 | 2017 | 92 | |
| 3 | 2019 | 86 | |
| 4 | 2016 | 83 | |
| 5 | 2018 | 83 | |
| 6 | 2017 | 82 | |
| 7 | 2017 | 76 | |
| 8 | 2013 | 73 | |
| 9 | 2021 | 70 | |
| 10 | 2017 | 68 | |
| 11 | 2014 | 63 | |
| 12 | 2017 | 60 | |
| 13 | 2021 | 49 | |
| 14 | 2015 | 48 | |
| 15 | 2019 | 47 | |
| 16 | 2012 | 41 | |
| 17 | 2012 | 33 | |
| 18 | 2020 | 30 | |
| 19 | 2020 | 29 | |
| 20 | 2014 | 28 |
About Hui Xie
Hui Xie is a scholar working on Cancer Research, Molecular Biology, Parasitology, Genetics and Sensory Systems, having authored 61 papers that have together received 2.0k indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (7 papers), Breast Cancer Treatment Studies (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Circular RNAs in diseases (5 papers), Epigenetics and DNA Methylation (5 papers), Wnt/β-catenin signaling in development and cancer (3 papers) and Extracellular vesicles in disease (3 papers). The work is most often cited by research in Cancer Research (727 citations), Molecular Biology (1.2k citations), Parasitology (78 citations), Oncology (283 citations) and Pulmonary and Respiratory Medicine (286 citations). Hui Xie has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Ziyi Fu, Shui Wang, Ruilan Wang, Xiaowei Wu, Xiaoxiao Meng, Wenbin Zhou, Yong Zhu, Yangyang Cui, Yue Huang and Zhongdao Wu. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Oncology, Journal of Cellular Physiology, Journal of Cellular and Molecular Medicine and Journal of Biomedical Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.